Midgut Neuroendocrine Tumor

• CLINICAL_TRIALS research · 2026-01-14
  Clinical Trial Update: Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine Tumors [Phase 2]

  This Phase 2 trial evaluates Abemaciclib in patients with advanced, unresectable, and/or metastatic digestive system neuroendocrine tumors; …

• CLINICAL_TRIALS research · 2025-09-02
  Clinical Trial Update: Randomized Interval Assessment Trial of Lu177-Dotatate in Slowly Progressive G1-2 Advanced Midgut Neuroendocrine Tumors [Phase 3]

  Phase 3 randomized trial evaluating Lutetium-177 dotatate in slowly progressive Grade 1-2 advanced midgut neuroendocrine tumors. The study i…

• CLINICAL_TRIALS research · 2025-05-20
  Clinical Trial Update: Prophylactic Cholecystectomy in Midgut NETs Patients Who Require Primary Tumor Surgery. [NA]

  This clinical trial assesses prophylactic cholecystectomy in patients with midgut neuroendocrine tumors who require primary tumor surgery; t…

• CLINICAL_TRIALS research · 2025-04-10
  Clinical Trial Update: Exploration of Molecular Biomarkers for Lu-177 DOTATATE Therapy in Midgut Neuroendocrine Tumor [NA]

  This clinical trial update reports on exploring molecular biomarkers associated with Lutetium-177 DOTATATE therapy in patients with midgut n…

• CLINICAL_TRIALS withdrawal · 2024-04-29
  Clinical Trial Update: A Clinical Trial Evaluating the Safety of Combining Lutathera(R) and Azedra(R) to Treat Mid-gut Neuroendocrine Tumors [Phase 1, Phase 2]

  This clinical trial update notes that the Phase 1/2 study evaluating the safety of combining Lutathera and Azedra for midgut gastroenteropan…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2022-07-05
  Clinical Trial Update: Capecitabine ON Temozolomide Radionuclide Therapy Octreotate Lutetium-177 NeuroEndocrine Tumours Study [Phase 2]

  Phase 2 clinical trial investigating capecitabine with temozolomide and radiolabeled peptide therapy (Lutetium-177) for midgut and pancreati…

• CLINICAL_TRIALS trial_result · 2020-12-30
  Clinical Trial Update: Efficacy and Safety Study in Pancreatic or Midgut Neuroendocrine Tumours Having Progressed Radiologically While Previously Treated With Lanreotide Autogel® 120 mg [Phase 2]

  Phase 2 trial updating the efficacy and safety of lanreotide Autogel in pancreatic and midgut neuroendocrine tumors after progression on pri…

• CLINICAL_TRIALS trial_result · 2020-06-01
  Clinical Trial Update: Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors [Phase 2]

  Pazopanib hydrochloride is being studied in a Phase 2 trial for progressive carcinoid tumors (neuroendocrine tumors); the study status is ac…